Top 5 Stocks to Buy Now
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free CNSL Stock Alerts

Cambridge Nutritional Sciences (CNSL) Competitors

GBX 1.72 -0.04 (-2.00%)
As of 12:02 PM Eastern
Compare

CNSL vs. CEL, BCE, OTT, FOX, and CZN

Should you buy Cambridge Nutritional Sciences stock or one of its competitors? MarketBeat compares Cambridge Nutritional Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cambridge Nutritional Sciences include Celadon Pharmaceuticals (CEL), Beacon Energy (BCE), Oxford Technology 3 Venture Capital Trust (OTT), Fox Marble (FOX), and Curzon Energy (CZN). These companies are all part of the "communication" industry.

How does Cambridge Nutritional Sciences compare to Celadon Pharmaceuticals?

Cambridge Nutritional Sciences (LON:CNSL) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Celadon Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Celadon Pharmaceuticals Neutral

Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.51-£3.03M£0.602.86
Celadon Pharmaceuticals£123.38K66.61-£4.97M-£7.98N/A

Cambridge Nutritional Sciences has a beta of 1.93, suggesting that its stock price is 93% more volatile than the broader market. Comparatively, Celadon Pharmaceuticals has a beta of -0.26, suggesting that its stock price is 126% less volatile than the broader market.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Celadon Pharmaceuticals' net margin of -9,520.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Celadon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Celadon Pharmaceuticals -9,520.00%-131.82%-34.40%

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by company insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Cambridge Nutritional Sciences beats Celadon Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Beacon Energy?

Cambridge Nutritional Sciences (LON:CNSL) and Beacon Energy (LON:BCE) are both small-cap communication companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Beacon Energy's net margin of 0.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Beacon Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Beacon Energy N/A -196.88%-6.61%

1.6% of Cambridge Nutritional Sciences shares are held by institutional investors. Comparatively, 5.0% of Beacon Energy shares are held by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are held by company insiders. Comparatively, 5.9% of Beacon Energy shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Beacon Energy has lower revenue, but higher earnings than Cambridge Nutritional Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.51-£3.03M£0.602.86
Beacon EnergyN/AN/A-£1.58MN/AN/A

Cambridge Nutritional Sciences has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market. Comparatively, Beacon Energy has a beta of -0.3, meaning that its stock price is 130% less volatile than the broader market.

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Beacon Energy'saverage media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Beacon Energy Neutral

Summary

Cambridge Nutritional Sciences beats Beacon Energy on 7 of the 9 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Oxford Technology 3 Venture Capital Trust?

Cambridge Nutritional Sciences (LON:CNSL) and Oxford Technology 3 Venture Capital Trust (LON:OTT) are both small-cap communication companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Oxford Technology 3 Venture Capital Trust's net margin of 0.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Oxford Technology 3 Venture Capital Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Oxford Technology 3 Venture Capital Trust N/A N/A N/A

Oxford Technology 3 Venture Capital Trust has lower revenue, but higher earnings than Cambridge Nutritional Sciences. Oxford Technology 3 Venture Capital Trust is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.51-£3.03M£0.602.86
Oxford Technology 3 Venture Capital Trust-£85K0.00N/A-£2.70N/A

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Oxford Technology 3 Venture Capital Trust'saverage media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Oxford Technology 3 Venture Capital Trust Neutral

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Cambridge Nutritional Sciences beats Oxford Technology 3 Venture Capital Trust on 7 of the 8 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Fox Marble?

Cambridge Nutritional Sciences (LON:CNSL) and Fox Marble (LON:FOX) are both small-cap communication companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Fox Marble's net margin of -282.21%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Fox Marble's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Fox Marble -282.21%-38.15%-10.32%

Cambridge Nutritional Sciences has a beta of 1.93, meaning that its share price is 93% more volatile than the broader market. Comparatively, Fox Marble has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

Fox Marble has lower revenue, but higher earnings than Cambridge Nutritional Sciences. Fox Marble is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.51-£3.03M£0.602.86
Fox MarbleN/AN/A-£2.04M-£0.05N/A

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Fox Marble'saverage media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Fox Marble Neutral

1.6% of Cambridge Nutritional Sciences shares are held by institutional investors. Comparatively, 2.2% of Fox Marble shares are held by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are held by insiders. Comparatively, 19.6% of Fox Marble shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Cambridge Nutritional Sciences beats Fox Marble on 7 of the 10 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Curzon Energy?

Cambridge Nutritional Sciences (LON:CNSL) and Curzon Energy (LON:CZN) are both small-cap communication companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Curzon Energy has lower revenue, but higher earnings than Cambridge Nutritional Sciences. Curzon Energy is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.51-£3.03M£0.602.86
Curzon EnergyN/AN/AN/A-£0.01N/A

Cambridge Nutritional Sciences has a beta of 1.93, meaning that its share price is 93% more volatile than the broader market. Comparatively, Curzon Energy has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Curzon Energy's net margin of 0.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Curzon Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Curzon Energy N/A N/A -272.65%

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Curzon Energy'saverage media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Curzon Energy Neutral

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by insiders. Comparatively, 5.3% of Curzon Energy shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Cambridge Nutritional Sciences beats Curzon Energy on 9 of the 9 factors compared between the two stocks.

Get Cambridge Nutritional Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNSL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNSL vs. The Competition

Export
MetricCambridge Nutritional SciencesMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£4.08M£2.85B£6.48B£2.78B
Dividend YieldN/A2.01%2.68%6.16%
P/E Ratio2.8616.3124.66365.72
Price / Sales0.5174.09529.8986,253.73
Price / CashN/A146.5427.9227.85
Price / Book0.432.2110.847.93
Net Income-£3.03M£99.80M£3.56B£5.89B
7 Day Performance-4.72%-0.99%1.71%-0.87%
1 Month Performance-10.02%-1.99%0.48%-0.76%
1 Year Performance-49.05%-8.16%32.98%70.67%

Cambridge Nutritional Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNSL
Cambridge Nutritional Sciences
N/AGBX 1.72
-2.0%		N/A-53.3%£4.08M£8.06M2.863,200
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat		N/AN/A£8.22M£123.38KN/A2,780
BCE
Beacon Energy
N/AGBX 3.20
+3.2%		N/A+67,650.0%£3.87MN/AN/A44,600
OTT
Oxford Technology 3 Venture Capital Trust
N/AN/AN/AN/A£2.13M-£85KN/A203
FOX
Fox Marble
N/AGBX 0.03
flat		N/A-23.1%£957KN/AN/A10,600

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:CNSL) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel